Ashley Gallagher, MA

Direct contracting can boost transparent drug pricing and help independent pharmacies earn fairly while patients save on generic medications.

The decision removes risk statements regarding cardiovascular disease, breast cancer, and probable dementia from the boxed warning.

As shrinking dispensing margins make it harder for pharmacies to keep their doors open on prescriptions alone, many are turning to clinical services as a lifeline.

GLP-1 therapies lower C-reactive protein and tumor necrosis factor-alpha, signaling cardiovascular protection; pharmacists tackle cost

Phase 3 OCEANIC-STROKE shows asundexian cuts recurrent ischemic stroke by 26% on top of antiplatelets, without more major bleeding.

Pharmacists guide smokers in choosing effective OTC cessation aids, enhancing success rates with tailored nicotine replacement therapies for cravings and withdrawal relief.

Real-world data shows empagliflozin cuts mortality in broader type 2 diabetes patients, supporting wider sodium-glucose co-transporter 2 inhibitor use with careful safety monitoring.

Phase 3 data show oral fenebrutinib slows primary progressive multiple sclerosis disability progression versus ocrelizumab, with early upper-limb gains and a manageable safety profile.

CDC updates vaccination guidelines, emphasizing individual choice for COVID-19 and standalone chickenpox shots, while addressing vaccine hesitancy and misinformation.

TrumpRx drives Most-Favored-Nation drug pricing, cutting US costs for glucagon-like peptide-1, insulin, and fertility medications.

Pharmacists push for provider status and PBM overhaul as IRA policies squeeze pharmacies—what it means for access to vaccines, PrEP, and vital meds.

Pfizer's phase 2b study reveals promising results for its monthly GLP-1 therapy, enhancing weight loss and medication adherence in obesity management.

Novo Nordisk's CagriSema shows significant improvements in blood glucose control and weight loss for type 2 diabetes patients in recent trial results.

Inhaled Technosphere insulin revolutionizes diabetes management for children and pregnant women, addressing treatment adherence and psychological barriers effectively.

A plant-based lifestyle intervention can lead to diabetes remission and weight loss, transforming traditional diabetes management strategies.

High-dose vitamin D3 shows promise in improving metabolic health for type 2 diabetes patients, enhancing glycemic control alongside traditional treatments.

A recent survey reveals that over half of US patients face challenges with prescription costs, highlighting the need for better cost transparency and support.

Pharmacists enhance travel medicine by offering tailored consultations, risk assessments, and vaccine management, ensuring safe international travel for patients.

Consultant pharmacists enhance vaccination efforts in long-term care, addressing challenges like vaccine fatigue while advocating for age-friendly care and improved patient outcomes.

The Pharmacy Quality Alliance enhances patient outcomes by addressing social determinants of health through effective community partnerships and pharmacist involvement.

PQA releases the SDOH Resource Companion Guide, highlighting successful partnerships and strategies to address health-related social needs effectively.

Consultant pharmacists enhance long-term care by integrating vaccination strategies, educating staff, and addressing the unique needs of older adults.

Lumateperone shows promising remission rates for major depressive disorder, offering hope for sustained relief in adults when combined with antidepressants.

Fremanezumab significantly reduces migraine days in children and adolescents, offering a vital preventive option for managing episodic migraines.

Gestational diabetes significantly impacts postpartum cardiovascular health, especially in women over 35, highlighting the need for timely interventions.

Educational interventions and pharmacist engagement enhance patient safety in OTC medication use, addressing knowledge gaps and promoting responsible self-care practices.

Mavacamten shows promise in treating adolescent obstructive hypertrophic cardiomyopathy, significantly improving heart function and safety in a pivotal trial.

Pharmacists play a crucial role in preventing OTC drug abuse through proactive interventions and effective warning measures, according to recent research findings.

GSK announces promising phase 3 trial results for bepirovirsen, a potential treatment for chronic hepatitis B, showing significant functional cure rates.

Coping strategies significantly influence psychological health and functional capacity in COPD patients, highlighting the need for effective management.